Plasma p-tau217 can reliably detect preclinical Alzheimer disease

Plasma phosphorylated tau 217 (p-tau217) can reliably detect Alzheimer disease (AD) pathology in the preclinical stage, according to a meta-analysis published online Dec. 1 in JAMA Neurology.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup